The global apheresis market is projected to reach USD 2.06 billion by 2021, at a CAGR of 7.7% during the forecast period of 2016 to 2021. Growth in this market is majorly driven by the rising prevalence of chronic diseases and growing number of complex surgeries. Similarly, the increasing number of organ transplant procedures also supports the growth of the market. In this report, the market is segmented by product, procedure, technology, application, and region. Based on technology, the market is mainly segmented into centrifugation and membrane separation technologies.
The centrifugation technology segment accounted for the largest share in 2015. This segment is also projected to register the highest growth during the forecast period. The large share and high growth in this market can be attributed to the advantages offered by centrifugation over membrane separation. Centrifugation is used for the apheresis of any blood component, whereas the use of membrane separation is limited to plasma collection and plasma exchange, and it cannot remove cellular elements.
Based on application, the market is segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, and other applications. In 2015, the plasmapheresis segment accounted for the largest share of the market. Growth in the plasmapheresis segment can be attributed to the increasing use of plasma fractionation products in the treatment of various diseases and the growing demand for plasma and its components from pharmaceutical and biopharmaceutical companies.
In 2015, North America commanded the largest share of the market, followed by Europe. The U.S. is a prime market for apheresis due to greater accessibility to advanced blood collection technologies and presence of a well-established healthcare infrastructure in the country. The Asia-Pacific market is expected to witness the highest growth in the coming years primarily due to the growing focus of manufacturers in this region.
Major players in the global apheresis market are Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), Cerus Corporation (U.S.), B. Braun Melsungen AG (Germany), HemaCare Corporation (U.S.), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan).
Research Coverage • Detailed insights on all the submarkets, based on application (plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, and other applications), this can help market players to identify high growth segments in the apheresis market. • The report also provides information on key players in this market and their growth strategies and recent developments. This can help the company to assess the competition at global and regional levels in a better manner. • Key insights and market sizing for the different therapeutic procedures of the apheresis market, namely, therapeutic plasma exchange (TPE), therapeutic cytapheresis, photopheresis, and extracorporeal immunoadsorption (ECI). • Country-wise market size and forecast for all the subsegments. Thus, not only the high growth product, procedure, technology, and application; the market size numbers provided in the report will also enable market players to identify key geographic markets, and thereby strategize global marketing efforts to achieve sustainable revenue growth in the coming years. • It provides key insights on market dynamics, such as drivers, restraints, opportunities, and challenges for this market.
Reasons to Buy the Report The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies to increase market shares.
This report provides insights on the following pointers: • Market Penetration: Comprehensive information on the product portfolios offered by top players in the apheresis market. The report analyzes the market by product type across all regions • Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and product launches in the apheresis market • Market Development: Comprehensive information on lucrative emerging markets, based on product, procedure, technology, application, and region • Market Diversification: Exhaustive information about new products, growing regions, recent developments, and investments in the apheresis market • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, and manufacturing capabilities of leading players in the apheresis market
Our reports have been used by over 10K customers, including:
Thalassemia Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Thalassemia Global Clinical Trials Review, H2, 2018" provides an overview of Thalassemia clinical trials scenario.This report provides top line data relating to the clinical trials on Thalassemia. Report...
Hereditary Hematological Disorders Drug Development Pipeline Review, 2018 Summary Thalassemia refers to a group of inherited blood disorders that affect the body’s ability to produce hemoglobin and red blood cells. Symptoms include paleness, frequent infections and jaundice. Predisposing factors...